David E. Wheadon's most recent trade in Vaxart Inc was a trade of 95,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 95,400 | 95,400 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 16,000 | 46,750 (0%) | 0% | 0 | Common Stock | |
| Sotera Health Co | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 19,132 | 74,912 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Indivior Plc | David E. Wheadon | Non-Executive Director,Chairman | Purchase of securities on an exchange or from another person at price $ 8.43 per share. | 27 Feb 2025 | 10,000 | 10,000 (0%) | 0% | 8.4 | 84,281 | Ords |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 95,400 | 95,400 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 16,000 | 30,750 (0%) | 0% | 0 | Common Stock | |
| Sotera Health Co | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 55,780 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 44,224 | 44,224 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 7,375 | 14,750 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 1,904 | 1,904 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 990 | 990 (0%) | 0% | 0 | Common Stock | |
| Sotera Health Co | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 35,691 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 44,224 | 44,224 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 7,375 | 7,375 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,000 | 5,000 | - | - | Option (right to buy) | |
| Sotera Health Co | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 19,979 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Vaxart Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 65,700 | 65,700 | - | - | Stock Option (right to buy) | |
| Karuna Therapeutics Inc | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 8,500 | 8,500 | - | - | Option (right to buy) | |
| Sotera Health Co | David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 9,336 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") |